Macrophages play a relevant role in innate and adaptive immunity depending on the balance of the stimuli received. From an analytical and functional point of view, macrophage stimulation can be segregated into three main topics: innate, classic and alternative pathways. These differential activations result in the expression of specific sets of genes involved in the release of pro-or anti-inflammatory stimuli. In previous works, it has been described an enhancement of metabolic pathways in the activation process and, in the present work, we have analyzed whether these metabolic pattern changes depend on the signaling pathway pathways. However, stimulation through the alternative pathway has minor metabolic effects. The molecular basis of the differences between these two types of behavior appear to involve a switch in the expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase resulting in a more active enzyme and an increase in the levels of fructose-2,6-bisphosphate.
Introduction
The innate immune system acts as the first line of defense and functions by recognizing highly conserved sets of molecular patterns (PAMPs) through a limited set of germ line encoded receptors called pattern-recognition receptors (PRRs). Toll-like receptors (TLRs), a class of PRRs, have the ability to recognize pathogens or pathogen-derived products and initiate signaling events leading to activation of innate host defense (1, 2) . Macrophages play an essential role in the immune response and normal tissue development by producing proinflammatory mediators and through clearance of pathogens and apoptotic cells by phagocytosis. Macrophages participate actively in the inflammatory response by releasing cytokines, chemokines and factors that recruit additional cells to sites of infection or tissue injury or alteration (3, 4) . It has been described that macrophages could undergo different activation processes depending on the stimuli received (5, 6): The classic activation, that can be induced by in vitro culture of macrophages with IFN-γ and LPS (inducing TNF-α production), is associated with high microbicidal activity, pro-inflammatory cytokine and reactive oxygen species (ROS) production and cellular immunity; the innate activation, that is mediated in culture by ligation of receptors such as TLRs, most of which are expressed by cells of the monocytemacrophage lineage, and is associated with microbicidal activity and pro-inflammatory cytokine production; the alternative activation, that can be mimicked in vitro after culture with IL-4, IL-13, glucocorticoids, immune complexes or IL-10 and is associated with tissue repair, tumor progression and humoral immunity.
Some authors also distinguish macrophage deactivation, which is induced by cytokines such as IL-10 or TGF-β, or by ligation of inhibitory receptors such as CD200 receptor or CD172a, and is related to antiinflammatory cytokine production and reduced MHC class II expression.
Under normal conditions, macrophages are recruited, invade and phagocyte at sites of infection.
However, deregulated clearance of activated macrophages may lead to septic shock or chronic inflammatory diseases, including atherosclerosis and rheumatoid arthritis (4) . Interestingly, in addition to playing a crucial role in immunity, some of the mammalian TLRs have been described to regulate bodily energy metabolism, mostly through acting on adipose tissue. This has recently opened new avenues of research on the role of TLRs in pathologies related to metabolism, such as obesity, insulin resistance, metabolic syndrome or atherosclerosis (7) . The accumulation of fatty acids, above all cholesterol in LDL form, is the main reason why lipid metabolism has been studied in macrophages in the atherosclerosis framework. Recent works have built a fatty acid bridge between diet and immune system due to the induction of TLR expression by some fatty acids (8) . However, few are know on central metabolism patterns in macrophages since the work of Newsholme and collaborators in the 90's (9-11). Here we will apply a system biology approach to shed some light in the crosstalk between signal transduction and central metabolism in macrophages. We studied whether the distinct stimulation pathways required different energy demands or have different metabolic patterns. To achieve these goals, tracer-based metabolomics experiments have been used and combined with analysis of the expression of markers of activation. Following the normal activation process of the macrophages, cells were fed with [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]-glucose, a non radioactive isotope of glucose which behaves as the "non-label" glucose but will incorporate [ 13 C] carbons to the metabolite end products (i.e. lactate, glutamate) and in the ribose of RNA. This tracer has been broadly used before (12) . Our data show that activated macrophages are essentially glycolytic cells and a clear cut-off between the classic/innate activation and the alternative pathway exists. Interestingly, activation through TLR-2, -3, -4 and -9 results in similar patterns of metabolic activation, despite the use of at least in part distinct signaling pathways and expression of different sets of genes. Treatment of animals and preparation of peritoneal macrophages. Animals were used aged 8 to 12-weeks as follows: Four days prior to the assay, mice were i.p. injected 2.5 ml of 3% (weight/vol) of thioglycollate broth (13) . Elicited peritoneal macrophages were prepared from light-ether anesthetized mice (4-6 animals per After resuspension of the pellet in the extraction medium, PFK-2 activity was assayed at pH 8.5 with 5 mM MgATP and 5 mM Fru-6-phosphate, 15 mM Glc-6-phosphate. One unit of PFK-2 activity is the amount of enzyme that catalyzes the formation of one pmol of Fru-2,6-P 2 per min (14) .
Materials and Methods

Chemicals
Metabolite assays. Fru-2,6-P 2 was extracted from cells (24-well plates) after homogenization in 100 μl of 50 mM NaOH followed by heating at 80 o C for 10 min. The metabolite was measured by the activation of the PPi-dependent phosphofructo-1-kinase (14) . Lactate and glucose were measured enzymically in the culture medium. NO release was determined spectrophotometrically by the accumulation of nitrite and nitrate in the medium (phenol red-free). Nitrate was reduced to nitrite, and this was determined with Griess reagent (13) by adding 1 mM sulfanilic acid and 100 mM HCl (final concentration). After a first reading of the absorbance at 548 nm, naphthylenediamine (1 mM in the assay) was added and the absorbance was compared with a standard of NaNO 2 . Results were expressed as the amount of nitrite and nitrate released per mg of cell protein.
Cytokine assay. The accumulation of TNF-α and IL-6 was measured per triplicate using commercial kits Microarray analysis. Normalized expression data were obtained from NCBI GEO dataset GDS2429 (15) using GEOquery package from Bioconductor (16) . Differential expression for the following comparisons was tested using limma Bioconductor package (17): a) naïve mature macrophage vs. classic activated macrophage and, b) alternatively activated macrophage. Two gene lists were generated after each comparison and they were ranked according to the test statistic for subsequent Gene Set Enrichment Analysis (GSEA). Enrichment of gene sets of interest in each list was accomplished using the GSEA method as described by Mootha et al. (18) . We used "Which genes?" (http://www.whichgenes.org/) to retrieve the REACTOME (19) pathways as gene sets. The genes from the two lists were also mapped into canonical pathways using Ingenuity Pathway Analysis software (Ingenuity Systems, see Supplementary material).
GCMS sample preparation and procedure. The macrophages cultures (10 cm dishes) were washed twice with ice-cold PBS and culture media was replaced by 50% enriched [1,2- Statistical analysis. The data shown are the means + SD of three or four experiments. Statistical significance was estimated with Student's t test for unpaired observations. A P value of less than 0.05 was considered significant. and TNF-α synthesis (Fig. 1C) .
Results
Distribution
Previous data suggested the relevance of carbohydrate metabolism in the commitment for activation of macrophages (27) (28) (29) (30) . In this regard, we investigated the glucose consumption and fate in macrophages activated through the innate, classic and alternative pathways. As Fig. 2 shows, two clear profiles were observed in terms of glucose consumption and lactate release: TLR activation promoted an enhancement in the glycolytic flux to lactate that has temporally dependent profiles, but can be grouped into two categories:
one from 0 to 4h and a second flux rate between 4 and 12h. Indeed, when the same experiment was performed with [1,2-
13
C 2 ]-glucose, the distribution of [ 13 C]-glucose metabolites, according to the scheme depicted in Fig. 3 , allowed the measurement of the precise contribution of these time-dependent fluxes in activated macrophages. From 0 to 4h the glycolytic activity was much lower than from 4 to 12h (Fig. 4A) .
Interestingly, stimulation through the alternative pathway, despite to influence the expression of a specific set of genes (vide infra), exhibited a metabolic profile that essentially matched that of control cells. Also, and in agreement with previous work, macrophages displayed a metabolic flux that involved the conversion of glucose into lactate by more than 95%, regardless the activation pathway considered (Fig. 4B) . The metabolic features revealed by glucose consumption and lactate release are followed by a basal consumption of glutamine and glutamate production (Fig. 2) . Besides, low enrichment in glutamate and RNA ( Fig. 4B and 5B) evidenced the high glycolytic pattern in peritoneal macrophages. Peritoneal macrophages are quiescent cells; however, when the macrophage cell line RAW 264.7 cells was used and kept overnight with 1% FCS, stimulation after 12h under these conditions revealed that the basal proliferation rate of these cells did not influence the metabolic profile associated to the macrophage activation process. As Fig. 5A shows, RAW 264.7 cells follow a similar mass isotope distribution in lactate than peritoneal macrophages under basal conditions. However, proliferation induces higher metabolic fluxes and [
13 C] enrichment in ribose and glutamate (Fig. 5B) .
Gene profiling in stimulated macrophages.
The previous experiments showed that carbohydrate metabolism in macrophages is fundamentally glycolytic and that the rate of glucose consumption is lower in alternatively activated macrophages than in classic activation. We hypothesized that the expression levels of genes involved in energetic pathways may differ between the two types of macrophage activation. To test this hypothesis we compared the functional enrichment (in up or down-regulated genes) of the following REACTOME (19) pathways: "Glycolysis", "Pyruvate metabolism and TCA cycle" and "Electron Transport These data suggest that classic activation has a stronger effect on the gene expression of genes related with the energetic metabolism, favoring the up-regulation of genes from the glycolytic pathway and repression of genes encoding for proteins that participate in the oxidative phosphorylation.
PFK-2/FBPase-2 isoenzyme changes in activated macrophages. The aforementioned differences in
transcription of the glycolysis gene-set between classic and alternative activation of macrophages allowed us hypothesize that PFK-2, one of the key enzymes of the pathway, could be regulated at the protein and/or enzymatic level. Accordingly, the expression of the isoforms of PFK-2 and the levels of Fru-2,6-P 2 were determined under these conditions as an indication of the capacity of these cells to metabolize glucose (14, 31) . As Fig. 6B shows, resting macrophages expressed the L-type isoenzyme of PFK-2, but not the uPFK-2 isoenzyme, resulting in low steady state levels of Fru-2,6-P 2 . However, as result of the activation through the classic and innate pathway, but not the alternative pathway, a robust expression of the uPFK-2 isoenzyme occurred, concomitant with an up to 9-fold rise in the PFK-2 activity and 5-fold increase in the levels of Fru-2,6-P 2 . Interestingly, the levels of expression of uPFK2, and more importantly, the enzyme activity and intracellular concentration of Fru-2,6-P 2 exhibited parallel profiles for each activation condition. Moreover, neither IL-4, IL-10 nor IL-13 were able to change the expression pattern of PFK-2 nor to increase Fru-2,6-P 2 levels. To evaluate the capacity of these IL to influence the response to LPS co-stimulation studies were done. As Fig. 6C shows, when combined IL-10 and IL-4 with LPS, the intracellular levels of Fru-2,6-P 2 were only minimally influenced with respect to the LPS condition and an important expression of uPFK-2 occurred, despite to maintain a certain level of L-PFK-2 expression.
Discussion
Previous work established that peritoneal macrophages are essentially glycolytic cells (10, 11, 28, 29, 32, 33) . Compared with other cell types macrophages use mainly anaerobic glycolysis in the metabolization of glucose, and the measured flux in isolated cells is ca. 10% of the actual capacity through 6-phosphofructo-1-kinase, one of the enzymes that controls the glycolytic pathway (29) . In addition to this, glutamine is converted into glutamate and aspartate and less than 10% is being oxidized, at the time that fatty acids appear to be the main substrates for oxidative metabolism (28) . In the present work, it has been assessed the metabolic profiles associated to stimulation of macrophages through three well-defined activation-pathways, using a metabolomic approach. The data obtained show that regardless the stimulation pathway involved, macrophages remain glycolytic cells and accelerate notably the conversion of glucose into lactate when challenged through the classic/innate activation pathways; however, the activation through the alternative pathway exerted minimal effects on the basal consumption of glucose. One of the relevant regulators of glucose metabolism is the rise in the levels of Fru-2,6-P 2 that in turn activates the flux through 6-phosphofructo-1-kinase (30, 34, 35) . Fru-2,6-P 2 is synthesized/degraded by PFK-2/FBPase-2 activities. Four genes encode the PFK-2 in higher mammals. The L-type is encoded by the PFKB1 gene and is mainly expressed in liver and a splicing variant is expressed in muscle. This enzyme has a balanced kinase/bisphosphatase ratio and unless the bisphosphatase activity is inhibited, it maintains low levels of Fru-2,6-P 2 through a futile cycle of synthesis and degradation of the metabolite (34, 35) . The uPFK-2 encoded by the PFKB3 gene has a higher kinase activity (ca. 10:1 kinase:bisphosphatase), is induced by hypoxia and can be regulated by phosphorylation, playing a role in the high glycolytic rate of various cell types, such as cancer cells (30, (36) (37) (38) . A relevant finding of this work is the observation that concomitant to the classic/innate activation there is a switch in the expression of the PFK-2/FBPase-2 from the L-type to the uPFK-2 isoenzyme. Interestingly, this form exhibits a higher capacity to accumulate Fru-2,6-P 2 in macrophages, due to its lower bisphosphatase activity compared with the L-type, which results in an enhancement in the levels of Fru-2,6-P 2 at the time that there is an increase in the enzymatic activity determined in vitro and in the glycolytic flux. Moreover, it is remarkable the substitutions between the two isoenzymes and, in fact, the protein levels of L-PFK-2 almost disappear and are substituted by the uPFK-2 in the course of TLR-2, -3, -4 or -9 activation, despite the use of non-redundant signaling pathways; i.e. MyD88 dependent and independent pathways. This switch between PFK-2 isoenzymes is absent in macrophages activated through the alternative pathway and studies on the molecular basis of this transcriptional control are in progress. Regarding the mass isotopomer distribution in both resting and activated macrophages, the distribution of the label is essentially identical confirming the minor impact of cell activation among switching between glucose fueling pathways. Although the three activation pathways studied involve changes in the expression of a large number of genes, the present work shows that only classic and innate In conclusion the data show that the stimulation of macrophages through the classic, innate and alternative pathways exhibits, as expected, a distinctly expression of activation markers due to different signaling events involved in each pathway. However, the innate pathway activation shows a higher glycolytic rate due to a switch in the expression of PFK-2 isoenzymes that appears to be a common event after LPS/IFNγ or TLR-2, -3, -4 -9 stimualtion. Despite the differences in glucose consumption and lactate release, label distribution analysis shows that there is a common metabolic pattern followed regardless the activation pathway.
Legends to Figures. Fig. 1 . Characterization of macrophages stimulated through the classic, innate and alternative pathways. Peritoneal macrophages were maintained in culture and stimulated with the indicated stimuli: LPS/IFN-γ (250 ng/ml and 20 ng/ml, respectively); LPS (100 ng/ml); IL-13, IL-4, IL-10 (20 ng/ml each); LTA (5 µg/ml); polyI·C (25 µg/ml); CpG (3 µg/ml); staurosporine (100 ng/ml). The levels of the indicated proteins were determined by Western blot (panel A). The extent of apoptosis/necrosis was determined by the staining with annexin V/propidium iodide, respectively (panel B). The release of IL-6, TNF-α, and nitrite/nitrate to the culture medium was determined as described in the methods section (C). Results show the mean + SD of five experiments. *P<0.01 vs. the vehicle condition. Fig. 1 . The levels of the L-PFK-2 and uPFK-2 isoenzymes were determined by Western blot using specific antibodies. Cell extracts were prepared and the activity of PFK-2 was determined in vitro. The levels of Fru-2,6-P 2 were determined in cell extracts after collection of the cell pellets in 50 mM NaOH at 80ºC (panel B). Co-treatment of cells with LPS and IL-10 or IL-4 results in a decrease in Fru-2,6-P 2 content (panel C). Results show the mean + SD of five experiments. *P<0.01 vs. the vehicle condition; #P<0.05 vs. the LPS condition (panel C).
Supplementary material
The gene lists (1) classic activation and (2) alternative activation of macrophage were generated and analyzed as described in the Methods section of the manuscript. Here we show the enrichment plots from Gene Set Enrichment Analysis (GSEA) for the three REACTOME pathways analyzed, together with the genes mapped into canonical pathways generated by Ingenuity Pathway Analysis software (Ingenuity 
